RGNX logo

RGNX

REGENXBIO Inc.

$9.06
+$0.17(+1.91%)
18
Overall
--
Value
18
Tech
--
Quality
Market Cap
$467.76M
Volume
420.90K
52W Range
$5.04 - $12.22
Target Price
$30.08
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$7.6M$4.6M$10.4M$218.5M$35.2M$154.6M$470.3M$112.7M$90.2M$83.3M
Total Revenue
$7.6M$4.6M$10.4M$218.5M$35.2M$154.6M$470.3M$112.7M$90.2M$83.3M
COST OF GOODS SOLD
Cost of Revenue
$-98.0K$-98.0K$-1.7M$-9.6M$8.2M$35.7M$51.8M$54.5M$37.2M$33.6M
GROSS PROFIT
Gross Profit
$6.1M$3.6M$8.7M$208.9M$27.0M$118.9M$418.5M$58.2M$53.0M$49.8M
OPERATING EXPENSES
Operating Expenses
$29.2M$69.0M$84.6M$120.8M$176.0M$230.1M$260.8M$321.1M$320.8M$285.1M
Research & Development
$17.3M$45.5M$57.2M$83.9M$124.2M$166.3M$181.4M$242.5M$232.3M$208.5M
Research Expense
$17.3M$45.5M$57.2M$83.9M$124.2M$166.3M$181.4M$242.5M$232.3M$208.5M
Selling, General & Administrative
$11.9M$23.6M$27.2M$36.9M$51.8M$63.8M$79.3M$85.3M$88.5M$76.6M
General & Administrative Expenses
$11.9M$23.6M$27.2M$36.9M$51.8M$63.8M$79.3M$85.3M$88.5M$76.6M
Salaries & Wages
$-2.9M$-7.0M$-10.6M$-16.6M------$40.8M$40.3M$38.5M
Depreciation & Amortization
$-80.0K$-544.0K$-2.7M$-4.0M$7.2M$8.4M$9.6M$12.9M$17.3M$16.2M
Depreciation & Amortization
$-80.0K$-544.0K$-2.7M$-4.0M$7.2M$8.4M$9.6M$12.9M$17.3M$16.2M
Other Operating Expenses
$31.0K$-102.0K$116.0K$42.0K$3.7M$6.3M$12.1M$11.3M$13.4M$13.6M
OPERATING INCOME
Operating income
$-23.1M$-65.3M$-75.9M$88.1M$-149.0M$-119.2M$160.0M$-262.9M$-268.1M$-233.3M
EBITDA
$-22.4M$-60.9M$-68.7M$108.9M$-91.5M$-96.8M$177.1M$-244.3M$-246.3M$-221.6M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$20.0K--------$771.0K$26.3M$23.3M$6.9M--
Intinc
------$8.9M--------$9.1M$12.1M
Net Non-Operating Interest Income/Expense
$326.0K$1.9M$2.7M$16.0M--$-771.0K$-23.7M$22.9M$9.1M$5.0M
Gain on Sale of Securities
----$479.0K$-39.0K$48.6M$9.7M$6.8M$5.4M$11.3M$18.7M
Other Income/Expense
----$-479.0K$-176.1M$-51.5M$-14.0M$-7.5M$5.4M$-11.3M$-18.7M
Other Special Charges
------$176.1M$3.0M$4.3M$719.0K------
SPECIAL ITEMS
Restructring And Mn A Income
----------------$3.7M$400.0K
Special Income Charges
--------------$-7.5M$-3.7M$-2.1M
Impairment of Capital Assets
------------------$2.1M
PRE-TAX INCOME
EBIT
$-22.8M$-63.4M$-73.2M$104.1M$-97.5M$-105.2M$167.5M$-257.2M$-263.6M$-237.8M
Pre-Tax Income
$-22.8M$-63.4M$-73.2M$104.1M$-97.5M$-106.0M$141.2M$-280.4M$-263.6M$-227.1M
INCOME TAX
Tax Provision
--$-435.0K$-16.6M$4.2M$-2.8M$5.2M$13.4M$-84.0K$-152.0K$-10.7M
NET INCOME
Net Income
$-22.8M$-63.0M$-73.2M$99.9M$-94.7M$-111.3M$127.8M$-280.3M$-263.5M$-227.1M
Net Income (Continuing Operations)
$-22.8M$-63.0M$-73.2M$99.9M$-94.7M$-111.3M$127.8M$-280.3M$-263.5M$-227.1M
Net Income (Discontinued Operations)
$-22.8M$-63.0M$-73.2M$99.9M$-94.7M$-111.3M$127.8M$-280.3M$-263.5M$-227.1M
Net Income (Common Stockholders)
$-23.8M$-63.0M$-73.2M$99.9M$-94.8M$-111.3M$127.8M$-280.3M$-263.5M$-227.1M
Normalized Income
------------------$-225.7M
TOTALS
Total Expenses
$29.1M$68.9M$82.9M$111.1M$184.2M$265.8M$312.6M$375.6M$358.0M$318.7M
SHARE & EPS DATA
Average Shares Outstanding
$9.2M$26.4M$29.9M$33.4M$36.7M$37.3M$42.4M$43.2M$43.7M$49.5M
Average Shares Outstanding (Diluted)
$8.8M$26.5M$29.9M$36.6M$36.7M$37.3M$43.9M$43.2M$43.7M$49.5M
Shares Outstanding
$26.3M$26.5M$31.7M$36.4M$37.1M$42.5M$42.9M$43.5M$44.4M$50.1M
Basic EPS
----$-2.45$2.99$-2.58$-2.98$3.01$-6.5$-6.02$-4.59
Basic EPS (Continuing Operations)
--------$-2.58$-2.98$3.01$-6.5$-6.02$-4.59
Diluted EPS
$-2.59$-2.38$-2.45$2.73$-2.58$-2.98$2.91$-6.5$-6.02$-4.59
Diluted EPS (Continuing Operations)
--------$-2.58$-2.98$2.91$-6.5$-6.02$-4.59
OTHER METRICS
Accrued Preferred Stock Dividends
$988.0K------------------
Non Recurring Operation Expense
--------------$7.5M$7.5M$7.5M
Other Gand A
$11.9M$23.6M$27.2M$36.9M$51.8M$63.8M$79.3M$85.3M$88.5M$76.6M
Other Impairment Of Capital Assets
------------------$2.1M
Otherunder Preferred Stock Dividend
$988.0K------------------
Preferred Stock Dividends
$988.0K------------------
Rent And Landing Fees
$11.9M$23.6M$27.2M$36.9M------------
Restruct
----------------$3.7M$400.0K

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2RGNX$9.06+1.9%420.90K
3
4
5
6

Get REGENXBIO Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.